Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Bacillus Calmette‐Guérin (BCG) vs mitomycin

Time to progression

Bacillus Calmette‐Guérin (BCG) showed no clear difference in time to progression (absolute effect size estimates based on event… compared with mitomycin C (MMC) (low certainty).

1 finding from 1 review

Intravesical Bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer 2020 · Cochrane Headline outcomes only
HR 0.96 [0.73, 1.26]
6 studies · 1622 participants
Low